In addition to protecting rats from HFD-induced obesity, we found that central OT infusion improved glucose tolerance and significantly reduced insulin secretion during the glucose tolerance test, indications of increased insulin sensitivity. This evidence concerns the gene INS and obesity due to melanocortin 4 receptor deficiency.